Receive a weekly summary and discussion of the top papers of the week by leading researchers in the field.

In Circulation ; h5-index 165.0

This month's highlights from the subspecialty journals cover atrial fibrillation, microvascular dysfunction, progression of atherosclerosis, a stroke quality initiative, and a subanalysis of DAPAHF (Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients With Chronic Heart Failure). Applying an artificial intelligence algorithm to sinus rhythm ECGs independently predicts atrial fibrillation in a study from Circulation: Arrhythmia and Electrophysiology. In Circulation: Genomic and Precision Medicine, the association of alcohol intake with atrial fibrillation was evaluated according to genetic predisposition to atrial fibrillation. In Circulation: Cardiovascular Interventions, a randomized trial of ranolazine treatment for microvascular dysfunction is reported. In Circulation: Cardiovascular Imaging, baseline 18F-sodium florid activity by positron emission tomography was associated with incident coronary calcification. The Target: Stroke quality initiative from the American Heart Association is reported in Circulation: Cardiovascular Quality and Outcomes. A substudy in Circulation: Heart Failure evaluates the benefit of dapagliflozin across cohorts of duration of heart failure from DAPA-HF.

**

2021-Jan-26